Adapt Your Commercial Strategy for Growth in 2024

The signals of a return to growth for the life sciences and analytical instruments industry are emerging. As commercial leaders gear up for 2024, they must prepare to adapt their go-to-market strategy to improve  operational efficiency.

Leading life sciences and analytical instruments companies are focusing on the following for 2024:

• Reducing costs: rationalize sales, marketing and service investments to align with the new growth curve.
• Investing in post-sales customer experience: determine the investments required to avoid possible customer churn and NPS detractors.
• Planning to deploy AI: use AI to accelerate innovation, enhance productivity, improve quality and personalize offerings.
• Leveraging revenue operations: create a seamless and consistent customer journey and optimize the efficiency and effectiveness of the revenue-generating processes and activities.

To learn more about how Alexander Group can assist you with your commercial strategy, please complete the form and a Life Sciences practice lead will be in contact with you to schedule a complimentary discussion on planning best practices.